Latest Brain tumor Stories
Procedure was accomplished using the new Edge(TM) radiosurgery system for the precise, efficient, non-invasive treatment of cancer MIAMI, Oct.
The supplement is intended to provide an overview of available knowledge regarding the use of NovoTTF Therapy for the treatment of recurrent glioblastoma, as well as its development for the treatment
LOS ANGELES, Oct.
HEIDELBERG, Germany, Oct.
ASHEVILLE, N.C., Oct.
HOUSTON, Oct. 24, 2014 /PRNewswire/ -- Burzynski Research Institute, Inc. (BRI) announced today that the U.S.
Six new members elected at ABTA annual meeting Chicago, IL (PRWEB) October 22, 2014 The American Brain Tumor Association (ABTA) – the first and now
Cancer Survivor Shares Personal Story During National Breast Cancer Awareness Month RENO, Nev., Oct.
In-demand research report “Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM”
NuvOx Pharma, a biotechnology company based in Tucson, Arizona, has received a $1Million grant from the National Cancer Institute (NCI) “Nanoparticle-based Sensitizer for Radiation Therapy of
- The act of sweetening by admixture of some saccharine substance.